Friday, 18 November 2016

Menopausal Hot Flashes Therapy Market USD 4.7 Billion by 2020

Menopausal Hot Flashes Therapy Market 2013-2020 report assesses the worldwide menopausal hot flashes treatment market to reach about USD 4.7 Billion in 2020, at a CAGR of 3.8% from 2016 to 2020 - iHealthcareAnalyst, Inc.

Visit the Menopausal Hot Flashes Therapy Market 2013-2020 report www.ihealthcareanalyst.com/report/menopausal-hot-flashes-...

Hot flushes are a typical side effect of the menopause experienced by the greater part of the menopausal ladies as a sudden sentiment warmth or warmth in the body, which are generally most serious over the face, neck and mid-section. Hot flushes may happen all alone however are frequently joined by night sweats or intemperate sweating amid the day.

The worldwide menopausal hot flashes treatment showcase division depends on treatment (hormonal treatment, estrogen, progestin, blend treatment, non-hormonal treatment).

The worldwide menopausal hot flashes treatment showcase report gives advertise measure (Revenue USD Million 2013 to 2020), piece of the overall industry, showcase patterns and gauges development patterns (CAGR%, 2016 to 2020). The worldwide menopausal hot flashes treatment statistical surveying report is partitioned by geology (territorial and nation based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

1. Treatment Type

1.1 Hormonal Therapy

1.1.1 Estrogen

1.1.2 Progestin

1.1.3 Combination Therapy

1.2 Non-hormonal Therapy

2. Topography (Region, Country)

2.1 North America (U.S., Canada)

2.2 Latin America (Brazil, Mexico, Rest of LA)

2.3 Europe (U.K., Germany, France, Italy, Spain, Rest of EU)

2.4 Asia Pacific (Japan, China, India, Rest of APAC)

2.5 Rest of the World

3. Organization Profiles

3.1 Allergan plc

3.2 Bayer AG

3.3 Hisamitsu Pharmaceutical Co., Inc.

3.4 Merck and Co., Inc.

3.5 Novartis International AG

3.6 Novo Nordisk

3.7 Pfizer, Inc.

3.8 Teva Pharmaceutical Industries Ltd.

iHealthcareAnalyst, Inc. is a worldwide social insurance statistical surveying and counseling organization giving business sector investigation, and focused insight administrations to worldwide customers. The Company distributes syndicate, custom and counseling grade medicinal services reports covering creature social insurance, biotechnology, clinical diagnostics, human services informatics, social insurance administrations, restorative gadgets, therapeutic hardware, and pharmaceuticals.

iHealthcareAnalyst, Inc. gives industry members and partners with deliberately broke down, impartial perspective of market progression and business openings inside its scope regions.

No comments:

Post a Comment

Note: only a member of this blog may post a comment.